$PG (+2,31%) | Procter & Gamble Q1'25 Earnings Highlights

🔹 Core EPS: $1.93 (Est. $1.90) 🟢; UP +5% YoY

🔹 Revenue: $21.47B (Est. $21.98B) 🔴; DOWN -1% YoY

🔹 Organic Revenue Growth: +2% (Est. +2.06%) 🟡

FY 2025 Guidance:

🔹 Core EPS: $6.91 to $7.05 (Est. $6.95) 🟡

🔹 All-in Sales Growth: +2% to +4%

🔹 Organic Sales Growth: +3% to +5% (Est. +3.43%) 🟡

🔹 Operating Cash Flow Productivity: 90%

🔹 Capital Spending: 4% to 5% of FY25 Net Sales

🔹 Dividends: Expected ~$10B

🔹 Share Repurchases: $6B to $7B

Q1 Segment Performance:

🔹 Health Care Organic Sales: +4% (Est. +3.5%) 🟢

🔹 Fabric & Home Care Organic Sales: +3% YoY

🔹 Grooming Organic Sales: +3% YoY

🔹 Beauty Organic Sales: DOWN -2% YoY

🔹 Baby, Feminine & Family Care Organic Sales: Flat YoY

Operational Metrics:

🔹 Commodity Cost Headwind: $200M; Impact of $0.08/share

🔹 Foreign Exchange Impact: Neutral

🔹 Incremental Restructuring Charges: $800M in Q1, primarily related to Argentina operations

🔹 Operating Cash Flow: $4.3B

🔹 Adjusted Free Cash Flow Productivity: 82%